A review of quality of life measures in dry eye questionnaires

Cornea

Volumn 33, Issue 2, 2014, Pages 215-218

  Grubbs, Joseph R ^a,b   Tolleson Rinehart, Sue ^a,b   Huynh, Kyle ^c,d   Davis, Richard M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Dry eye; Quality of life; Questionnaires

Indexed keywords

ARTICLE; DRY EYE; HUMAN; IMPACT OF DRY EYE ON EVERYDAY LIFE QUESTIONNAIRE; MEDICAL LITERATURE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OCULAR SURFACE DISEASE INDEX; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SYSTEMATIC REVIEW; TEXAS EYE RESEARCH AND TECHNOLOGY CENTER QUESTIONNAIRE; VALIDITY;

DRY EYE SYNDROMES; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 84892960304     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000038     Document Type: Article

References (26)

1. Nichols KK. Patient-reported symptoms in dry dye disease. Ocul Surf. 2006;4:137-145.
2. Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol. 2010;21:310-316.
3. Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409-415.
4. Pouyeh B, Viteri E, Feuer W, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153:1061-1066.e3.
5. Rajagopalan K, Abetz L, Mertzanis P, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health. 2005;8:168-174.
6. Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412-1419.
7. Buchholz P, Steeds CS, Stern LS, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 2006;4:155-161.
8. The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.
9. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000; 118:615-621.
10. Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications. Acta Ophthalmol. 2012. doi: 10.1111/aos. 12012. [epub ahead of print].
11. Viso E, Rodríguez-Ares MT, Abelenda D, et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53:2601-2606.
12. Guillemin I, Begley C, Chalmers R, et al. Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: Revisiting the standards. Ocul Surf. 2012;10:84-99.
13. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer. 2009;45:347-353.
14. Abetz L, Rajagopalan K, Mertzanis P, et al. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011;9:111.
15. Hernández-Molina G, Sánchez-Hernández T. Clinimetric methods in Sjögren's syndrome. Semin Arthritis Rheum. 2013;42:627-639.
16. AllerganI. Ocular Surface Disease Index (OSDI) [The Dry Eye Zone website]. 1995. Available at: Http://www.dryeyezone.com/encyclopedia/ documents/OSDI.pdf. Accessed March 31, 2013.
17. Pflugfelder SC, Baudouin C. Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol. 2011;5: 1575-1583.
18. Vitale S, Goodman LA, Reed GF, et al. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye. Health Qual Life Outcomes. 2004;2:44.
19. McDonald M, D'Aversa G, Perry HD, et al. Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT-) therapy with clinical outcomes: Tools for predicting response. Curr Eye Res. 2010;35:880-887.
20. Fairchild CJ, Chalmers RL, Begley CG. Clinically important difference in dry eye: Change in IDEEL-symptom bother. Optom Vis Sci. 2008;85: 699-707.
21. RAND. National Eye Institute Visual Functioning Questionnaire-25 (VFQ-25) [National Eye Institute website]. 2000. Available at: Http://www.nei.nih.gov/ resources/visionfunction/vfq-ia.pdf. Accessed March 31, 2013.
22. Nichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea. 2002;21:578-583.
23. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610-618.
24. Dry Eye Questionnaire [Tear Film & Ocular Surface Society web site]. 2002. Available at: Http://www.tearfilm.org/dewsreport/pdfs/ Questionnaire%20DEQ%20questionnaire%20(Caffery).pdf. Accessed March 31, 2013.
25. Narayanan S, Miller WL, Prager TC, et al. The diagnosis and characteristics of moderate dry eye in non-contact lens wearers. Eye Contact Lens. 2005;31:96-104.
26. Srinivasan S, Joyce E, Jones LW. Tear osmolality and ferning patterns in postmenopausal women. Optom Vis Sci. 2007;84:588-592.